Congenital and vascular retinal abnormalities

Chapter 47 Congenital and vascular retinal abnormalities





Congenital hypertrophy of the retinal pigment epithelium


Congenital hypertrophy of the retinal pigment epithelium (CHRPE) lesions are pigmented lesions of the retinal pigment epithelium (RPE) that are flat or very slightly raised, round or oval, and predominantly located at the mid-periphery as well as in the peripapillary or macular regions (Fig. 47.1). A pigmented and non-pigmented halo may surround lesions with multiple depigmented lacunae within the lesion. Depigmented CHRPEs are less common.1 Optical coherence tomography (OCT) demonstrates lack of photoreceptors overlying the lesion2 while absent autofluorescence shows a lack of lipofuscin. Fluorescein angiography demonstrates choroidal masking.3






Genetics


APC is an autosomal dominant disorder, with an incidence of 1 in 83007 that predisposes to malignancy and accounts for ~1% of all colorectal cancers. CHRPEs are associated with Gardner’s syndrome (APC with extracolonic manifestations such as osteoma and desmoid tumors) and Turcot’s syndrome (co-occurrence of FAP and medulloblastoma), and are found in APC families without extracolonic manifestations.7 All are caused by mutations within the APC gene on chromosome 5q21–22.8 CHRPEs are not seen in all individuals with the APC phenotype and when present suggest a mutation between codons 463 and 1387. In families where CHRPEs are present they are highly penetrant.


Most affected individuals with APC develop multiple adenomatous colorectal polyps between the second and fourth decades.9 Malignant transformation occurs in over 90% of patients by age 50 years. Tumor surveillance for gene carriers by colonoscopy begins from around 12 years and usually leads to elective colectomy. Polyps may also develop in the stomach, small bowel, and duodenum, the last being associated with a risk of malignant transformation. Ten percent of patients develop desmoid tumors: benign, locally invasive fibrous tissue tumors. Osteomas of the mandible and dental anomalies, such as missing or supernumerary teeth, are common.






Retinal astrocytic hamartoma


Retinal astrocytic hamartomas are benign glial tumors of the retinal nerve fiber layer frequently associated with tuberous sclerosis (see Chapter 65). Calcification can cause diagnostic confusion with retinoblastoma, although the mean age at diagnosis of retinoblastoma is around 2 years, whilst that of astrocytoma is 14.5 years.17 Progression from flat to nodular lesions can occur. Most lesions range from 0.5 to 5 mm in diameter. They are slow growing, but very occasionally exhibit more aggressive growth resulting in retinal exudation, vitreous hemorrhage, retinal detachment, retinochoroiditis, neovascular glaucoma, vitreous seeding,18 and globe perforation.19


TSC is associated with mutations in one of two tumor suppressor genes, Hamartin (TSC1) and Tuberin (TSC2). The encoded proteins form a cytoplasmic molecular complex that controls cell growth and survival signals conveyed through the P13K signal transduction pathway.20



Retinal capillary hemangioma


Retinal capillary hemangiomas (RCH), more correctly hemangioblastomas, are circumscribed, orange–red, round, vascular tumors with a prominent feeding and draining vessel (see Chapter 65). When sporadic, they are usually unilateral and unifocal. RCHs are a frequent association with von Hippel-Lindau syndrome (VHL, see Chapter 65), a multisystem, autosomal dominant, familial, cancer-predisposition syndrome. In VHL, the RCHs are often bilateral and multifocal.21 Fluorescein angiography shows early hyperfluorescence, late leakage, and distinguishes feeder vessels from draining venules; it highlights small peripheral RCHs, otherwise undetectable.22 B-scan ultrasound detects a mass lesion, measures basal dimensions, and detects subretinal fluid. A-scans show medium to high internal reflectivity.23 OCT can measure retinal thickness at the macula and monitor treatment response.24


RCHs are mostly located anterior to the equator usually superotemporally or, less frequently (10–15%), in the juxtapapillary region.25 Peripheral RCHs increase in size gradually with surface glial proliferation resulting in striae and traction. Visual loss occurs from leakage and exudation leading to cystoid macular edema, exudative and tractional retinal detachment.26 Neovascular glaucoma or cataract may occur.


Juxtapapillary hemangiomas are typically located temporal to the optic nerve. They may be sessile, usually endophytic or sometimes exophytic;27 they may remain stable for prolonged periods. This, together with close proximity to the optic nerve and the high likelihood of visual loss from nerve damage as a result of treatment, has led to many advocating observation until the macula is threatened by exudation and visual loss.27




Management


Treatment for RCHs includes laser photocoagulation, photodynamic therapy (PDT), cryotherapy, plaque radiotherapy, trans-scleral penetrating diathermy, vitreoretinal surgery, and systemic and intravitreal bevacizumab. For small (<1.5 mm in diameter), posteriorly located lesions, laser photocoagulation applied directly to the RCH and the feeder vessels is highly effective.30 More anteriorly located lesions and those with subretinal fluid may best be treated with cryotherapy.30 PDT with verteporfin has been used in both peripheral and juxtapapillary RCHs. PDT has a moderate effect using standard parameters as used in the TAP study.31 Complications include vitreous hemorrhage, subretinal hemorrhage, ischemic optic neuropathy, vascular occlusion, increase in subretinal fluid, and retinal detachment. PDT shows a relatively better outcome in juxtapapillary RCHs; more than one treatment may be required.31


Anti-VEGF (vascular endothelial growth factor) treatments, systemic or intravitreal, provide mixed results with a transient reduction in retinal edema but no significant reduction in tumor size or new tumor development.32,33



Cavernous hemangioma


This rare congenital vascular malformation (hamartoma) of the retina is usually sporadic, occasionally autosomal dominant with incomplete penetrance. Retinal lesions are unilateral and unifocal and, while often isolated, can be associated with intracranial or cutaneous cavernous hemangiomas: a neuro-oculocutaneous phakomatosis.34 Cavernous hemangiomas consist of saccular aneurysms resembling a cluster of grapes anywhere in the inner retina following the course of a retinal vein (Fig. 47.5). Visual loss may occur due to recurrent vitreous hemorrhage or macula involvement. Those located at the optic disk may compress nerve fibers.35 Fluorescein angiography demonstrates delayed filling with hyperfluorescent capping of the saccules. No leakage or exudation occurs.36





Jun 4, 2016 | Posted by in OPHTHALMOLOGY | Comments Off on Congenital and vascular retinal abnormalities

Full access? Get Clinical Tree

Get Clinical Tree app for offline access